The Young Blood Institute is a non-profit organization that aims to lessen the aging process later in life through young blood therapy and plasma replacement. It advances new uses for well established therapeutic plasma exchange therapies, which has the potential to rejuvenate the body's own stem cells, restore aging immune systems, and prevent the onset of many age-related disease conditions.
The institute's studies of Heterochronic Plasma Exchange (HPE)--the replacement of aged plasma with young plasma components--is ongoing. Subjects are individuals 50 years or older and have 2 or more age-related conditions and/or an immunologic or inflammatory abnormality.
In January 2018, the Life Extension Foundation (LEF) partnered with the Young Blood Institute to conduct human trials of swapping old blood with young blood.
